Evidence mapPaperPMID 42190015Full record

ArticleProceedings of the National Academy of Sciences of the United States of America2026

amyloid-predict and LLPS-predict: Predicting phase separation propensities in the intrinsically disordered proteome.

Samuel Lobo, Leif Griem, M Scott Shell, Joan-Emma Shea

Abstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Samuel LoboDepartment of Chemical Engineering, University of California, Santa Barbara, CA 93106.ORCID 0000-0002-1162-8798
Leif GriemDepartment of Chemical Engineering, University of California, Santa Barbara, CA 93106.
M Scott ShellDepartment of Chemical Engineering, University of California, Santa Barbara, CA 93106.ORCID 0000-0002-0439-1534
Joan-Emma SheaDepartment of Chemistry and Biochemistry, University of California, Santa Barbara, CA 93106.ORCID 0000-0002-9801-9273

Funding

HHS | NIH (NIH) 5R01AG056058-09NSF | BIO | Division of Molecular and Cellular Biosciences (MCB) 1716956NSF | BIO | Division of Molecular and Cellular Biosciences (MCB) 2423885
6 · The paper itself

Abstract

Amyloid formation and liquid-liquid phase separation (LLPS) are two important phenomena in cellular biology, linked to both normal physiological functions and various pathologies. Here, we present a computational framework that scores amyloid propensities (amyloid-predict) or LLPS propensities (LLPS-predict) from protein language model embeddings, enabling rapid proteome-wide annotation of peptides and residues. amyloid-predict achieves classification performance that exceeds existing AI and physics-based tools on a hexapeptide benchmark while enabling substantially faster high-throughput screening; notably, amyloid-predict is sensitive to subtle mutational effects and is influenced by sequence patterning and context rather than amino acid composition alone. We apply these protein language model classifiers to all the IDRs in the human proteome and uncover several protein categories with significant enhancement in amyloid and/or LLPS propensity, suggesting insights into the biological roles of these protein categories. For example, signaling receptors, carbohydrate-binding proteins, and Ca

Indexed as

AmyloidIntrinsically Disordered ProteinsProteomeHumansPhase SeparationAmyloidIntrinsically Disordered ProteinsProteomeamyloidsintrinsically disordered proteinsliquid–liquid phase separationneurodegenerative diseaseprotein language models

Identifiers

PMID42190015
PMCPMC13229271

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.